key: cord-0258746-es1ef3hv
authors: Kerner, Gaspard; Bouaziz, Matthieu; Cobat, Aurélie; Bigio, Benedetta; Timberlake, Andrew T; Bustamante, Jacinta; Lifton, Richard P; Casanova, Jean-Laurent; Abel, Laurent
title: A genome-wide case-only test for the detection of digenic inheritance in human exomes
date: 2020-02-07
journal: bioRxiv
DOI: 10.1101/2020.02.06.936922
sha: 99118458280b8f072f70f28c7b0ed19b48052d88
doc_id: 258746
cord_uid: es1ef3hv

Whole-exome sequencing (WES) has facilitated the discovery of genetic lesions underlying monogenic disorders. Incomplete penetrance and variable expressivity suggest a contribution of additional genetic lesions to clinical manifestations and outcome. Some monogenic disorders may therefore actually be digenic. However, only a few digenic disorders have been reported, all discovered by candidate gene approaches applied to at least one locus. We propose here a novel two-locus genome-wide test for detecting digenic inheritance in WES data. This approach uses the gene as the unit of analysis and tests all pairs of genes to detect pairwise gene x gene interactions underlying disease. It is a case-only method, which has several advantages over classic case-control tests, in particular by avoiding recruitment and bias of controls. Our simulation studies based on real WES data identified two major sources of type I error inflation in this case-only test: linkage disequilibrium and population stratification. Both were corrected by specific procedures. Moreover, our case-only approach is more powerful than the corresponding case-control test for detecting digenic interactions in various population stratification scenarios. Finally, we validated our unbiased, genome-wide approach by successfully identifying a previously reported digenic lesion in patients with craniosynostosis. Our case-only test is a powerful and timely tool for detecting digenic inheritance in WES data from patients. Significance statement Despite a growing number of reports of rare disorders not fully explained by monogenic lesions, digenic inheritance has been reported for only 54 diseases to date. The very few existing methods for detecting gene x gene interactions from next-generation sequencing data were generally studied in rare-variant association studies with limited simulation analyses for short genomic regions, under a case-control design. We describe the first case-only approach designed specifically to search for digenic inheritance, which avoids recruitment and bias related to controls. We show, through both extensive simulation studies on real WES datasets and application to a real example of craniosynostosis, that our method is robust and powerful for the genome-wide identification of digenic lesions.

Abstract. Whole-exome sequencing (WES) has facilitated the discovery of genetic lesions underlying monogenic disorders. Incomplete penetrance and variable expressivity suggest a contribution of additional genetic lesions to clinical manifestations and outcome. Some monogenic disorders may therefore actually be digenic. However, only a few digenic disorders have been reported, all discovered by candidate gene approaches applied to at least one locus. We propose here a novel two-locus genome-wide test for detecting digenic inheritance in WES data. This approach uses the gene as the unit of analysis and tests all pairs of genes to detect pairwise gene x gene interactions underlying disease. It is a case-only method, which has several advantages over classic case-control tests, in particular by avoiding recruitment and bias of controls. Our simulation studies based on real WES data identified two major sources of type I error inflation in this case-only test: linkage disequilibrium and population stratification. Both were corrected by specific procedures. Moreover, our case-only approach is more powerful than the corresponding case-control test for detecting digenic interactions in various population stratification scenarios. Finally, we validated our unbiased, genome-wide approach by successfully identifying a previously reported digenic lesion in patients with craniosynostosis. Our case-only test is a powerful and timely tool for detecting digenic inheritance in WES data from patients.

Significance statement. Despite a growing number of reports of rare disorders not fully explained by monogenic lesions, digenic inheritance has been reported for only 54 diseases to date. The very few existing methods for detecting gene x gene interactions from nextgeneration sequencing data were generally studied in rare-variant association studies with limited simulation analyses for short genomic regions, under a case-control design. We describe the first case-only approach designed specifically to search for digenic inheritance, which avoids recruitment and bias related to controls. We show, through both extensive simulation studies on real WES datasets and application to a real example of craniosynostosis, that our method is robust and powerful for the genome-wide identification of digenic lesions. 1 Next-generation sequencing (NGS) is now widely used and is gradually being 2 optimized for the detection of rare and common genetic variants underlying human diseases 3 (1-3). These advances, including whole-exome sequencing (WES), in particular, have led to 4 major new findings in the field of human genetics, particularly for rare and common 5 monogenic disorders (4) (5) (6) (7) (8) (9) (10) (11) (12) . The growing number of reports of incomplete penetrance or 6 variable expressivity of monogenic disorders suggests that additional genetic contributions, 7 other than the mono-or biallelic causal lesions, may contribute to clinical manifestations and 8 outcome (13, 14) . Digenic inheritance (DI) is the simplest genetic model of this type with 9 alleles at two different loci being necessary and sufficient to determine disease status (15, 16) . 10 The recently established Digenic Diseases DAtabase (DIDA) contains detailed information 11 about DI for 258 reported digenic combinations, corresponding to 54 conditions, since 1994 12 (17) . Well known examples relate to genetic modifier (GM) variants influencing the 13 expression of the clinical phenotype caused by a primary disease-causing mutation. Cystic 14 fibrosis (CF) is a classic example of a monogenic disease for which several GM variants have 15 been identified. An elegant WES-based study showed that two low-frequency (minor allele 16 frequency [MAF] < 5%) missense variants of DCTN4 were associated with the severity of 17 pulmonary Pseudomonas aeruginosa infections in CF patients (18) . One remarkable example 18 of DI explaining incomplete penetrance was recently provided for craniosynostosis. with DI were discovered in candidate gene studies, rather than through unbiased GW 26 statistical tests. In some cases, as for the cystic fibrosis example cited above, the defects were 27 identified by single-gene analyses of patients with known disease-causing variants at the 28 primary causal locus (18) . The craniosynostosis example is unique in that its discovery 29 involved a combination of GW single-gene analysis with prior knowledge of a common 30 variant from genome-wide association study (GWAS) data (19, 20) . For genetically 31 heterogeneous diseases, such as Alport syndrome, for which there are three known disease-32 causing genes, long-QT syndrome and Bardet-Biedl syndrome, each with more than a dozen 33 disease-causing genes, the proven digenic combinations display various modes of dominance 34 and involve the known disease-causing genes (21, 22) . However, other GM genes may be 35 hidden among genes with an unknown functional impact on disease, or even genes with no 36 detectable main effect. Similarly, many heritable conditions masked in apparently sporadic 37 cases, for which the genetic etiology remains unknown, may be due to DI.

There is, therefore, a need for two-locus GW methods for the detection of DI in NGS 39 data. WES is a NGS technique focusing on sequencing of protein-coding exons. It is currently 40 the most cost-effective NGS technology, as variants with a strong effect are more likely to 41 affect protein-coding sequences than non-coding sequences (23) (24) (25) . Very few methods have 42 been developed for detecting gene x gene interactions in the general context of rare variant 43 association studies; all techniques to date are based on case-control designs (26) (27) (28) . Here, we 44 propose a case-only approach to specific searches for DI. This design avoids the need for 45 control recruitment and the associated bias. Furthermore, case-only approaches have been 46 shown to be more powerful than classic case-control tests when common variants are tested for interaction, particularly in the context of GWAS (29) (30) (31) (32) (33) . Our novel approach is based on 48 the aggregation of rare variants within a gene as the unit of analysis, overcoming the lack of 49 power inherent to studies of rare variants. It also greatly decreases the computer time required for interaction analyses, by testing pairwise combinations at the gene level. The case-control design for interaction .

Classic statistical analyses of interaction are based on the comparison of and .

More specifically, the following classic case-control logistic regression model is often used to 84 test for interaction:

where it can be shown that the interaction coefficient, equals log ( ). This model also 87 takes main effects into account, by considering coefficient terms for each gene ( and ). In Subsequently, the null hypothesis of no interaction = 0 can be tested in a likelihood ratio 93 test (LRT) with one degree of freedom, in the presence or absence of main genetic effects 94 and/or covariate effects.

The case-only model 96 Interactions can also be assessed by focusing exclusively on cases, such that all the 97 information is provided by the 2x2 contingency table for affected individuals (Table 1 ). In 98 this situation, the standard full logistic regression model to test for interaction between genes 99 G k and G j is now written as

where is equal to log( ), is a matrix of covariates and a vector of coefficients. As 102 before, a LRT can be used to test the null hypothesis = 0.

Under the assumption that vectors G k and G j are not correlated, implying, in particular, that type I error to 0.00147 for = 0.1% (Table 2) , and 0.0535 for = 5% (Table S1 ). LD has 153 been identified as a possible cause of type I error inflation in case-only tests (35) . We (Table S2) , and a type I error of 0.00121 was 157 obtained at a nominal value of 0.1% when δ=2 Mb ( carriage rates of at least 35%; Table 2 ). The type I error was clearly lower, and improved as 185 the frequency of variants increased. For both tests, empirical type I errors were within the 186 boundaries of the confidence interval for = 0.1%, but remained slightly above the upper 187 limit of this interval for = 5% (Table S1) . (Table 3 and Table S4 ). Thus, provided that the search space was limited to pairs 216 of genes far enough apart to avoid LD and adjustment for PCs was applied when required, our 217 case-only test yielded reasonable type I error rates, similar to those for the analogous case-218 control approach. when one main effect was present ( Fig. 1 and SI Appendix, Fig. S5 ) and for assessments of 234 power at = 5% (data not shown).

Two-gene power scenarios. We then focused on two specific pairs of genes, without 236 (AHNAK, PKHD1L1, scheme 2G, see Table 4 ) and with (ARPP21, MACF1, scheme 2GS, see were not superimposed, indicating an effect of PS ( Fig. 2 and SI Appendix, Fig. S6 was only 60%. Finally, we also considered another specific pair of genes, including one 249 "common" (26% carriers) and one "rare" (5% carriers) gene (scheme 2GR, see Table 4 ). The Table S5 , and corresponds to the distribution found in the original paper 277 (20) . Thus, the two-locus genome-wide analysis focusing on genes harboring rare variants 278 together with the potential contribution of a common modifier variant was able to detect the 279 previously reported DI for craniosynostosis (20) . This analysis provides proof-of-concept that 280 our statistical test can detect DI without the need for biological assumptions concerning the 281 disease studied, even when the disease is very rare. Power curves are presented as in Figure 1 . Results are shown for the analysis of one "common" (AHNAK) and one "rare" gene (MPC1) (scheme 2GR Non carriers Note: Boundaries of the 95% confidence intervals are shown in brackets. Type I error values lying outside the 95% confidence interval's boundaries are in italic. a All pairs of genes with >15% of carriers of variants with MAF<5%. b Pairs of genes as Pg 0 but with genes apart by at least 2 Mb. c Pairs of genes as Pg 2 with adjustment on the first three principal components. d Pairs of genes as Pg 2 with >25% of carriers of variants with MAF<10%. e Pairs of genes as Pg 2 with >35% of carriers of variants with MAF<15%. 

Exome Analysis of Rare and Common Variants within the NOD Signaling Pathway

Exome sequencing as a tool for Mendelian disease gene discovery

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

Simple Genetics for a Complex Disease

Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

Genetic diagnosis by whole exome capture and massively parallel DNA sequencing

Affordable "exomes" fill gaps in a catalog of rare diseases

Exome and genome sequencing for inborn errors of immunity

Targeted capture and massively parallel sequencing of 12 human exomes

Exome sequencing identifies de novo pathogenic variants in FBN1 and TRPS1 in a patient with a complex connective tissue phenotype

Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia

Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing

Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

Digenic inheritance and genetic modifiers

Digenic inheritance in medical genetics

DIDA: A curated and annotated digenic diseases database

Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis

A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9

Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles

Evidence of digenic inheritance in Alport syndrome

Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

What can exome sequencing do for you?

A Robust Model-free Approach for Rare Variants Association Studies Incorporating Gene-Gene and Gene-Environmental Interactions

GxGrare: gene-gene interaction analysis method for rare variants from high-throughput sequencing data

Genome-wide gene-gene interaction analysis for nextgeneration sequencing

Limitations of the case-only design for identifying gene-environment interactions

Sample size requirements for association studies of gene-gene interaction

Exploiting geneenvironment interaction to detect genetic associations

Case-only Genome-wide Interaction Study of Disease Risk, Prognosis and Treatment

Case-only design to measure gene-gene interaction

Rare-variant association analysis: study designs and statistical tests

The role of linkage disequilibrium in case-only studies of gene-environment interactions

We would like to thank the patients and their families, whose cooperation was essential for collection of the data used in this study. We thank all members of the Laboratory of Human Genetics of Infectious Diseases for helpful discussions. Céline Desvallées, Tatiana Kochetkov, Dominick Papandrea, Cécile Patissier, Mark Woollett, Amy Gall and Yelena Nemirovskaya for their assistance.

The authors declare no competing interests.